fda novavax - Search News

Order byBest matchMost fresh

FDA, COVID-19 and vaccines

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and winter — even as a new Trump administration policy has thrown into question w...

· 1d · on MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

· 3d · on MSN

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

· 1d

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

· 1d

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 1d

WA vaccine scientists push back against FDA changes around COVID shots

According to the framework, published in the New England Journal of Medicine, new versions of the COVID vaccine — which have been developed annually to take into account emerging variants — will stil...

· 1d

New FDA rule could delay Covid vaccine rollout for healthy adults and kids

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

FDA won’t approve COVID shot for healthy, non-elderly population

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating their protein-based vaccine technology. The approval positions Novavax as the only non-mRNA COVID-19 vaccine with full FDA approval, offering a differentiated alternative amid growing mRNA fatigue.

2don MSN

FDA approves Novavax COVID vaccine with new conditions

President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House of Representatives try to overcome internal divisions about cuts to the Medicaid health program and tax breaks in high-cost coastal states.

Infectious Disease Advisor1d

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

2don MSN

FDA approves Novavax COVID-19 shot but with unusual restrictions

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without restrictions -- by its April 1 target date, according to two people with direct knowledge of the situation who spoke on condition of anonymity to discuss confidential agency matters.

2don MSN

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot.

1don MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

2don MSN

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.